Relative effectiveness of sunitinib versus everolimus in advanced pancreatic neuroendocrine tumors: an updated matching-adjusted indirect comparison.
Ishak, K Rael, M Hicks, M Mittal, S Eatock, M
Ishak, K
Rael, M
Hicks, M
Mittal, S
Eatock, M
Citations
Altmetric:
Abstract
A matching-adjusted indirect comparison (MAIC) of sunitinib and everolimus has been previously reported based on the RADIANT-3 everolimus trial. We performed an analysis using updated overall survival (OS) data based on sunitinib's trial (A6181111).
Affiliation
Evidera, Inc., Montreal, Canada
Description
Date
2018-08-31
Publisher
Collections
Keywords
Type
Article
Citation
Relative effectiveness of sunitinib versus everolimus in advanced pancreatic neuroendocrine tumors: an updated matching-adjusted indirect comparison. 2018, J Comp Eff Res